Literature DB >> 15168363

Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences.

Edward V Loftus1.   

Abstract

Although the incidence and prevalence of ulcerative colitis and Crohn's disease are beginning to stabilize in high-incidence areas such as northern Europe and North America, they continue to rise in low-incidence areas such as southern Europe, Asia, and much of the developing world. As many as 1.4 million persons in the United States and 2.2 million persons in Europe suffer from these diseases. Previously noted racial and ethnic differences seem to be narrowing. Differences in incidence across age, time, and geographic region suggest that environmental factors significantly modify the expression of Crohn's disease and ulcerative colitis. The strongest environmental factors identified are cigarette smoking and appendectomy. Whether other factors such as diet, oral contraceptives, perinatal/childhood infections, or atypical mycobacterial infections play a role in expression of inflammatory bowel disease remains unclear. Additional epidemiologic studies to define better the burden of illness, explore the mechanism of association with environmental factors, and identify new risk factors are needed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15168363     DOI: 10.1053/j.gastro.2004.01.063

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  897 in total

1.  Styrene maleic acid encapsulated raloxifene micelles for management of inflammatory bowel disease.

Authors:  Khaled Greish; Safa Taha; Anfal Jasim; Sara Abd Elghany; Ameera Sultan; Ali AlKhateeb; Manal Othman; Fang Jun; Sebastien Taurin; Moiz Bakhiet
Journal:  Clin Transl Med       Date:  2017-08-03

2.  Temporal genomewide expression profiling of DSS colitis reveals novel inflammatory and angiogenesis genes similar to ulcerative colitis.

Authors:  Kai Fang; Megan Bruce; Christopher B Pattillo; Songlin Zhang; Randolph Stone; John Clifford; Christopher G Kevil
Journal:  Physiol Genomics       Date:  2010-10-05       Impact factor: 3.107

3.  Contribution of the IBD5 locus to inflammatory bowel disease: a meta-analysis.

Authors:  Jian Wang; Xi Wang; Hong Yang; Dong Wu; Li Wang; Jiaming Qian
Journal:  Hum Genet       Date:  2011-01-30       Impact factor: 4.132

4.  Atherogenic diet causes lethal ileo-ceco-colitis in cyclooxygenase-2 deficient mice.

Authors:  James A Lin; Junji Watanabe; Nora Rozengurt; Ajay Narasimha; Martin G Martin; Jenny Wang; Jonathan Braun; Robert Langenbach; Srinivasa T Reddy
Journal:  Prostaglandins Other Lipid Mediat       Date:  2007-04-25       Impact factor: 3.072

5.  High-fat diet modulates non-CD1d-restricted natural killer T cells and regulatory T cells in mouse colon and exacerbates experimental colitis.

Authors:  X Ma; M Torbenson; A R A Hamad; M J Soloski; Z Li
Journal:  Clin Exp Immunol       Date:  2007-11-07       Impact factor: 4.330

6.  Novel Rho/MRTF/SRF inhibitors block matrix-stiffness and TGF-β-induced fibrogenesis in human colonic myofibroblasts.

Authors:  Laura A Johnson; Eva S Rodansky; Andrew J Haak; Scott D Larsen; Richard R Neubig; Peter D R Higgins
Journal:  Inflamm Bowel Dis       Date:  2014-01       Impact factor: 5.325

Review 7.  Challenges in designing a national surveillance program for inflammatory bowel disease in the United States.

Authors:  Millie D Long; Susan Hutfless; Michael D Kappelman; Hamed Khalili; Gilaad G Kaplan; Charles N Bernstein; Jean Frederic Colombel; Corinne Gower-Rousseau; Lisa Herrinton; Fernando Velayos; Edward V Loftus; Geoffrey C Nguyen; Ashwin N Ananthakrishnan; Amnon Sonnenberg; Andrew Chan; Robert S Sandler; Ashish Atreja; Samir A Shah; Kenneth J Rothman; Neal S Leleiko; Renee Bright; Paolo Boffetta; Kelly D Myers; Bruce E Sands
Journal:  Inflamm Bowel Dis       Date:  2014-02       Impact factor: 5.325

8.  Oral treatment with genistein reduces the expression of molecular and biochemical markers of inflammation in a rat model of chronic TNBS-induced colitis.

Authors:  Jan Seibel; Almut F Molzberger; Torsten Hertrampf; Ute Laudenbach-Leschowski; Patrick Diel
Journal:  Eur J Nutr       Date:  2009-02-21       Impact factor: 5.614

9.  Squamous dysplasia of the rectum in a patient with ulcerative colitis treated with 6-mercaptopurine.

Authors:  Rachel Greenberg; Bruce Greenwald; J Scott Roth; Olga Ioffe; Raymond Cross
Journal:  Dig Dis Sci       Date:  2007-08-24       Impact factor: 3.199

10.  Crohn's disease-associated colorectal cancer in Japan: report of four cases.

Authors:  Tadataka Hayashi; Toshio Nakamura; Kiyotaka Kurachi; Atsuko Fukazawa; Akihito Nakajima; Koichi Nakamura; Shohachi Suzuki; Hiroyuki Konno
Journal:  Int J Colorectal Dis       Date:  2007-08-24       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.